Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date Sort ascending | Expire Date | Purpose |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Competitive Revision Supplements to Existing T32 Programs to Include Institutional Research Training in Data Science for Infectious and Immune Mediated Diseases | NOT-AI-24-012 | NIAID | This Notice of Special Interest (NOSI) solicits competitive revision applications to support the expansion of existing National Institute of Allergy and Infectious Diseases (NIAID) T32 programs. This… More | ||
| Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) | RFA-RM-24-006 | RMOD | Many valuable and widely available data sets have been generated by multiple Common Fund programs. The purpose of this NOFO is to announce the availability of funding to demonstrate and enhance the… More | ||
| Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional) | RFA-MH-25-190 | NIMH | The purpose of this phased Notice of Funding Opportunity (NOFO) is to create a pipeline to accelerate the development and early validation of predictive tools and/or biomarkers to inform individual-… More | ||
| Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed) | RFA-DK-25-009 | NIDDK | This NOFO encourages applications from institutions that propose to establish research experiences in kidney technology development. Successful programs should include a collaborative capstone… More | ||
| Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) | RFA-TR-24-023 | NCATS | This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants… More | ||
| Medical Rehabilitation Research Resource (P50 Clinical Trial Optional) | RFA-HD-25-001 | NICHD | This Notice of Funding Opportunity (NOFO) invites grant applications from institutions/organizations that propose to build a Medical Rehabilitation Research Center. The centers will have a specific… More | ||
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) | PAR-24-173 | NHLBI | The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders… More | ||
| Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) | PAR-24-206 | NCATS | The objective of this Notice of Funding Opportunity (NOFO) is to invite new and renewal applications for the Rare Diseases Clinical Research Consortia (RDCRC) that comprise the Rare Diseases Clinical… More | ||
| Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed) | RFA-AI-24-019 | NIAID | The purpose of this notice of funding opportunity (NOFO) is to solicit applications to participate in the Immunobiology of Xenotransplantation Cooperative Research Program (IXCRP), a multi-center… More | ||
| Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria (R01 Clinical Trial Not Allowed) | RFA-AI-24-021 | NIAID | The purpose of this Notice of Funding Opportunity (NOFO) is to support milestone-driven projects focused on developing and utilizing novel predictive models, assays, tools, and/or platforms based on… More |